News
Market-Moving News Is on Tap for Seattle Genetics
Seattle Genetics (NASDAQ: SGEN) Adcetris is already a successful drug with global sales of about $600 million, but sales could climb even higher if the Food and Drug Administration approves its....
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A....
5 Top Biotech Stocks to Buy Now
Over the last five years, biotech stocks have trounced the performance of the S&P 500. One major reason why is the number of new drugs launched by biotech companies. More diseases than ever....
Is a Dividend Cut Coming From GlaxoSmithKline plc?
One of the attractions of investing in British drugmaker GlaxoSmithKline plc (NYSE: GSK) is its generous dividend yield, which lately has hovered at just a bit less than 6%. A yield that's so far....
Better Buy: Pfizer Inc. vs. Johnson & Johnson
With only one month remaining in 2017, it's pretty clear which big pharma stock has been the better pick this year between Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). J&J's share....
3 Biotech Stocks to Buy in December
Black Friday is past. So is Cyber Monday. But it's not too late to buy one of the best Christmas gifts of all -- biotech stocks. Even if your family and friends might prefer other kinds of....
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in....
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....
Better Buy: GlaxoSmithKline plc vs. Pfizer
Big drug companies can add an element of stability to investor portfolios. People get sick and need treatment whether the economy is booming or tanking. And big pharma tends to pay hefty....
UnitedHealth Wants to Be the Next Tech Incubator
It appears UnitedHealth Group (NYSE: UNH), the largest health insurer in the U.S., doesn't think the market is moving fast enough to develop new healthcare technology. On Tuesday, the company....
Healthcare Investing Risks and How to Mitigate Them
Healthcare is constantly coming under the fire of political and media attention, and biotech companies are going boom or bust on FDA approvals that are out of their control. But healthcare is also....
Why 2017 Was a Year to Remember for Illumina, Inc.
Happy days are here again for Illumina, Inc. (NASDAQ: ILMN).Shareholders were accustomed to huge gains for the stock in previous years, but they were sorely disappointed by the gene-sequencing....
3 Top Big Pharma Stocks to Buy Now
Big pharma stocks have been longtime favorites among investors for several reasons. The fact that they're big means that that they generate huge cash flow, which typically translates to attractive....
3 Dividend Stocks With Better Yields Than McDonald's
If you want fast food, McDonald's Corporation (NYSE: MCD) might be a good option. But despite the stock's status as a Dividend Aristocrat, there are better alternatives than McDonald's if you're....
Is First Data Corp. a Buy?
First Data Corp. (NYSE: FDC) is a payment-processing company that offers retailers card and mobile payment acceptance capabilities for online and point-of-sale (POS) transactions. First Data is....
Why Quidel Corporation Is Sinking
After the company announced that it is being sued by one of its customers, shares of Quidel Corporation (NASDAQ: QDEL), a maker of diagnostic testing equipment, fell 10% as of 3:45 p.m. EST on....
Biogen Inc. Buys Its Way Out of Competition
Biogen (NASDAQ: BIIB) is following the old saying, "If you can't beat 'em, join 'em" for its multibillion drug Tecfidera or, more accurately, "If you might not be able to beat 'em later, license....
Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.
These big pharma stocks have something for everyone. Income investors love the dividends Eli Lilly and Co. (NYSE: LLY) and Merck & Co., Inc. (NYSE: MRK) pay each quarter, while dreams of....
What Will the Average American Pay for Obamacare in 2018?
Big changes are in store for consumers who are planning to purchase an Obamacare (officially the Affordable Care Act, or ACA) plan in 2018. Though the enrollment period is ongoing and remains the....
3 Top Diabetes Stocks to Buy Now
Diabetes is huge problem for Americans. Between 1990 and 2010, the number of U.S. residents with diabetes tripled, and the number of new cases annually doubled. Both prevalence and costs....
5 Cancer Types With the Poorest Long-Term Outlook
There's arguably no scarier diagnosis a patient can receive from their doctor than cancer. But the grim reality, based on data from the National Cancer Institute's Surveillance, Epidemiology, and....
How to Diversify Your Healthcare Investments
On this week's episode of Industry Focus: Healthcare, analysts Kristine Harjes and Todd Campbell get back to basics and explain what you need to know about diversifying your portfolio, especially....